Correlation Between Uniqure NV and Adverum Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Uniqure NV and Adverum Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Uniqure NV and Adverum Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Uniqure NV and Adverum Biotechnologies, you can compare the effects of market volatilities on Uniqure NV and Adverum Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Uniqure NV with a short position of Adverum Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Uniqure NV and Adverum Biotechnologies.

Diversification Opportunities for Uniqure NV and Adverum Biotechnologies

0.38

Correlation Coefficient

Uniqure NV  Adverum Biotechnologies

Weak diversification

The 3 months correlation between Uniqure and Adverum is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Uniqure NV and Adverum Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adverum Biotechnologies and Uniqure NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Uniqure NV are associated (or correlated) with Adverum Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adverum Biotechnologies has no effect on the direction of Uniqure NV i.e., Uniqure NV and Adverum Biotechnologies go up and down completely randomly.

Pair Corralation between Uniqure NV and Adverum Biotechnologies

Given the investment horizon of 90 days Uniqure NV is expected to under-perform the Adverum Biotechnologies. In addition to that, Uniqure NV is 1.05 times more volatile than Adverum Biotechnologies. It trades about -0.07 of its total potential returns per unit of risk. Adverum Biotechnologies is currently generating about 0.02 per unit of volatility. If you would invest  469.00  in Adverum Biotechnologies on December 30, 2024 and sell it today you would lose (8.00) from holding Adverum Biotechnologies or give up 1.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Uniqure NV  vs.  Adverum Biotechnologies

Uniqure NV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Uniqure NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Adverum Biotechnologies

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Adverum Biotechnologies are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Adverum Biotechnologies is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Uniqure NV and Adverum Biotechnologies

The main advantage of trading using opposite Uniqure NV and Adverum Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Uniqure NV position performs unexpectedly, Adverum Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will offset losses from the drop in Adverum Biotechnologies' long position.

The idea behind Uniqure NV and Adverum Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.